Which of the following is your specialty? Neurology Pain specialist/Anesthesiology Headache specialist Primary care (MD, NP, PA) Other What is your highest attained degree? * MD/DO PhD PA NP RN Other, Please specify What is your highest attained degree? Other, Please specify Do you practice in the United States? * Yes No How many years have you been in practice? * <5 years 5 to <10 years 10 to <20 years 20 to <30 years 30 years or more How many patients with migraine do you see per month (on average): * Less than 10 10 - 30 31 - 50 More than 50 On average, what percentage of migraine patients in your practice are receiving preventive migraine treatments? * <10% 11% to 30% 31% to 60% >60% I don't know Calcitonin gene-related peptide (CGRP) is a novel pathway currently being investigated for its role in migraine: * True False I don't know Please rate your degree of familiarity with LY2951742 in the treatment of migraine: * Not at all familiar Somewhat familiar Very familiar Extremely familiar Based on the recommendations of the Neuromodulation Appropriateness Consensus Committee, which of the following nonpharmacologic treatments should be considered in the algorithmic treatment of migraine? * Transcutaneous supraorbital and supratrochlear nerve stimulation Vagus nerve stimulation Sphenopalatine ganglion stimulation A and B A and C I don’t know Which of the following pathways is the target of the pharmacologic agent TEV-48125? * Mu opioid receptor 5-HT2 serotonin receptor Calcitonin gene-related peptide None of the above I don't know Preventive migraine treatment should be considered in patients with: * Patients who are adherent to treatment Patients with chronic migraine Patients experiencing poor quality of life A and B B and C I don't know Which of the following best describes your current approach to migraine treatment: * I initiate discussion about preventive migraine treatment with all of my patients with migraines I initiate discussion about preventive migraine treatment with my patients with chronic migraines I initiate the discussion about preventive migraine treatment with my patients with episodic migraines I do not initiate the discussion about preventive migraine treatment, but if a patient brings it up, I discuss it then Other, Please specify Which of the following best describes your current approach to migraine treatment: Other, Please specify If you are interested in participating in the raffle for a $100/€100 Amazon gift card, please fill out the following: First Name: Last Name: Email: Leave this field blank
